Trump’s Drug Pricing Plan: What Does it Really Mean for Pharma?

Posted by Pratap Khedkar on Wed, Jul 04, 2018

Howard Deutsch co-authored this blog post with Pratap Khedkar.

President Donald Trump and HHS Secretary Alex Azar addressed the nation from the White House Rose Garden last week, introducing American Patients First, a drug pricing plan that Pres. Trump described as the “most sweeping action in history to lower the price of prescription drugs.” Let’s take a closer look, shall we?


>
Read More

What’s ‘BerkshAmazMorgan’ Really Capable Of?

Posted by Howard Deutsch on Tue, Feb 20, 2018

Bill Coyle, Paul Darling and Pratap Khedkar co-authored this post with Howard Deutsch.

This is the first post in a two-part series on the recently announced Berkshire Hathaway/Amazon/JPMorgan Chase healthcare venture. 

Look! Out in the distance! What’s that creature that’s destroying everything in its path? Why, it’s the scariest three-headed monster this side of Cerberus! It’s… it’s… it’s BerkshAmazMorgan! Will any of us be safe from this dreaded, rampaging beast?


>
Read More

Three Analytics Lessons From the Tennis Match-Fixing Scandal

Posted by Howard Deutsch on Fri, Jan 29, 2016

If you’re even just a casual tennis fan like me, then you’ve seen the report of a major scandal brewing on the professional tour. A joint investigation by BuzzFeed and the BBC cheekily called “The Tennis Racket” has purportedly uncovered evidence of widespread match-fixing. While the story, itself, is sensational, I’m particularly interested in three very important lessons that we can learn from this alleged betting scandal about getting it right with analytics.


>
Read More